Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

Clinical trial NCT04832971 · COMPLETED

Trial details

NCT number: NCT04832971
Sponsor: Arrowhead Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mixed Dyslipidemia

Start date: 2021-06-28
Primary completion: 2022-08-30
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.